Pharmaceutical compositions
US5364628A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Oct 22, 1993 |
| Grant date | Nov 15, 1994 |
| Priority date | — |
| Expiry date | Oct 22, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterised in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.